Overview explores new guideline recommendations for chronic coronary disease management, highlighting lifestyle changes and team approaches.
This overview provides a brief review of the 2023 American Heart Association, American College of Cardiology, American College of Clinical Pharmacy, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association guideline for the management of patients with chronic coronary disease. Clinical recommendations with a focus on a team-based approach, lifestyle modification, risk stratification, diagnostic testing, and pharmacologic and nonpharmacologic management are discussed.
No takes yet. Share an insight, caveat, or question.
Candice Falls (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: